| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 213,494 | 208,839 | 203,241 | 200,774 | | Cost of Revenue | 134,429 | 133,727 | 130,253 | 128,936 | | | Gross Profit | 79,065 | 75,112 | 72,988 | 71,838 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 58,046 | 56,476 | 55,489 | 57,944 | | Non Recurring | 2,413 | 1,584 |
-
| 322 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,695 | 17,052 | 17,499 | 13,572 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,489 | (1,210) | 1,672 | 5,352 | | Earnings Before Interest And Taxes | 21,309 | 15,842 | 19,171 | 18,924 | | Interest Expense | 139 | 237 | 114 | 159 | | Income Before Tax | 21,170 | 15,605 | 19,057 | 18,765 | | Income Tax Expense | 2,388 | 1,257 | 4,287 | 11,135 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,782 | 14,348 | 14,770 | 7,630 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,782 | 14,348 | 14,770 | 7,630 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,782 | $14,348 | $14,770 | $7,630 |
|
1.48% Nasdaq 
Income Statement
